Top Oversold TOP BUY Stocks in May 

• A.O. Smith Corporation (AOS) manufactures and sells gas and electric water heaters, boilers, tanks, and water treatment products to residential and commercial clients across the globe. A.O. Smith Corporation posted an all-time high return on invested capital of 17.6% in FY2018, a positive sign for potential investors! 

• Alphabet Inc. (GOOGL) is the global tech giant that offers advertising services through its wide array of products and service platforms including Google, Android, YouTube, and much more. Analysts project highly robust EPS growth for Alphabet of 15.96% per annum over the next 5 years, a very strong sign for investors! 

• CDK Global Inc. (CDK) is headquartered in Illinois and provides software solutions targeted at automotive retailers across the globe. CDK Global has displayed a strong ability to increase its profitability in recent history, growing its gross margin every year for the last 5 years from 39.1% in FY2014 to 48.0% in FY2018. 

• Centene Corporation (CNC) is the operator of a diversified portfolio of multinational healthcare enterprises that provide programs and services to under-insured and/or uninsured individuals in the United States. Over the last 5 years, Centene Corp. has generated extremely robust top-line revenue growth of 40.0% per annum.  

• Grand Canyon Education, Inc. (LOPE) is the provider of education services such as financial aid processing, human resources, and communication/marketing services to schools in the United States. Our models have highlighted Grand Canyon Education several times this year as a May Top Buy Stock Research Report, which you can check out here. 

• Leggett & Platt, Inc. (LEG) designs and produces a slew of engineered components and products through its Residential Products, Furniture Products, Industrial Products, and Specialized Products business segments. Leggett & Platt offers the most attractive dividend yield of 4.3% among all of the stocks highlighted above! 

• Medifast, Inc. (MED) and its subsidiaries manufacture and distribute weight loss, weight management, healthy living products, and other consumable health and nutritional products. Analysts’ consensus price target of $237/share for Medifast implies an attractive 67.95% upside from the stock’s last price!